Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

Multiple sclerosis (MS) is one of the most widespread disabling neurological conditions of young adults around the world. It affects almost 1 million people in the United States, and about 2.9 ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

Listen to Post Strategies to ease the burden Multiple Sclerosis (MS) is a chronic neurological condition that ...

Mothers with multiple sclerosis had an elevated incidence and prevalence of peripartum mental illness vs. mothers without MS ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.